FengHe Fund Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Astera Labs
ALAB
|
+$93.3M |
| 2 |
Advanced Micro Devices
AMD
|
+$54.5M |
| 3 |
Marvell Technology
MRVL
|
+$42.1M |
| 4 |
Credo Technology Group
CRDO
|
+$39.7M |
| 5 |
Albemarle
ALB
|
+$31M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertiv
VRT
|
+$33.4M |
| 2 |
Qualcomm
QCOM
|
+$14.9M |
| 3 |
GE HealthCare
GEHC
|
+$13.8M |
| 4 |
CFLT
Confluent
CFLT
|
+$13M |
| 5 |
Bitdeer Technologies
BTDR
|
+$12M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 81.22% |
| 2 | Materials | 8.74% |
| 3 | Communication Services | 5.29% |
| 4 | Financials | 1.83% |
| 5 | Consumer Discretionary | 1.6% |
Similar funds
FengHe Fund Management's Q2 2025 Portfolio in Review
As of Q2 2025, FengHe Fund Management held 37 positions worth $610M, up 129% from $267M the previous quarter. Its ten largest holdings account for 80% of the portfolio.
FengHe Fund Management deployed $239M of net new capital in Q2 2025, opening 12 new positions and adding to 5 existing holdings. Its largest new stake was Astera Labs: 1,180,848 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 81% of assets, up from 60% a quarter earlier, followed by Materials and Communication Services.
On the sell side, the largest reduction was Bitdeer Technologies, an estimated $12M trimmed.
- FengHe Fund Management's largest Q2 2025 buy was Astera Labs: 1,180,848 shares worth $107M.
- FengHe Fund Management added most to Advanced Micro Devices in Q2 2025, an estimated $54.5M increase.
- FengHe Fund Management's biggest Q2 2025 reduction was Bitdeer Technologies, cutting an estimated $12M.
- FengHe Fund Management fully exited Vertiv in Q2 2025, selling an estimated $33.4M.
- FengHe Fund Management's ten largest holdings make up 80% of its $610M portfolio in Q2 2025.
- FengHe Fund Management opened 12 new positions and closed 15 in Q2 2025.
- FengHe Fund Management's portfolio value rose 129% quarter-over-quarter to $610M.
Based on FengHe Fund Management's 13F filing for Q2 2025, filed 18 Jul 2025.